Map of Pancreatica Walks and Runs

Category Archives: Pancreatic Cancer

EUS for NETS

Depending on who you are and how you count, there are almost twenty kinds of pancreatic cancer. The main two that we generally speak of are adenocarcinoma of the pancreas which arises from the non-hormonal part of the organ and may be responsible for as much as 85% of cases, and pancreatic neuroendocrine tumors (NETS) […]

Share Button

IA and IV Gem and MITO-C

Recent advances over the drug agent gemcitabine for advanced pancreatic cancer are still in progress but appear to include the FOLFIRINOX (5-FU based) combination regimen and now recently Abraxane plus gemcitabine. Now comes a study by German researchers Lorenz and colleagues from the University of Frankfurt as published in the August issue of the journal […]

Share Button

FDA Approval: Nab-paclitaxel in Combination with Gemcitabine for Pancreatic Cancer

On September 6th the U.S Food and Drug Administration (FDA) – per its commendable fast track expedited review program for “orphan” diseases (which now includes pancreatic cancer) has approved nab-paclitaxel (trade name: Abraxane) for use in in combination with gemcitabine for metastatic pancreatic cancer. The previous drug agent officially approved by the FDA for pancreatic […]

Share Button
Page 15 of 30« First...10...1314151617...2030...Last »